| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/28/2007 | EP1474441B1 Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of ns3 (hepatitis c) |
| 03/28/2007 | EP1453532A4 Taojiks as modifiers of the beta-catenin pathway and methods of use |
| 03/28/2007 | EP1403371B1 Polypeptide having a cell death inhibitory activity |
| 03/28/2007 | EP1335733B1 Treatment of osteoporosis |
| 03/28/2007 | EP1259239B1 USE OF 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLO[1,5-b]PYRIDAZINE FOR THE TREATMENT OF NON-ULCERATIVE DYSPEPSIA |
| 03/28/2007 | EP1096936B1 Treatment of dyskinesia through mu selective opioid antagonists |
| 03/28/2007 | CN1938323A Silinane compounds as cysteine protease inhibitors |
| 03/28/2007 | CN1938025A Angiogenesis-affecting compounds and methods of use thereof |
| 03/28/2007 | CN1938008A Sustained-release preparations |
| 03/28/2007 | CN1936023A Diagnostic and monitoring methods for bone loss |
| 03/28/2007 | CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 03/28/2007 | CN1935277A Preparation for the prophylaxis of restenosis |
| 03/28/2007 | CN1935265A Grafted nano carbon anticancer prodrug, and its preparing method and use |
| 03/28/2007 | CN1935262A Use of red Nocardia cyto skeleton for preparing anti human papillomavirus medicine |
| 03/28/2007 | CN1935254A Neuregulin for treating cardio vascular disease, and its method and composition |
| 03/28/2007 | CN1935156A Remedy |
| 03/28/2007 | CN1935155A Remedy |
| 03/28/2007 | CN1935146A Anti-cytochrome oxidase P450 inhibitor medicinal composition and its use |
| 03/28/2007 | CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 03/28/2007 | CN1935134A Combination comprising combretastatin and anticancer agents |
| 03/28/2007 | CN1935116A Composition for oral cavity and selection method for product of oral cavity |
| 03/28/2007 | CN1307421C Method and compositions for overcoming resistance to biologic and chemotherapy |
| 03/28/2007 | CN1307303C Methods and compositions based on VEGF antisense oligonucleotides |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1306964C Decoy composition for treating and preventing inflammatory disease |
| 03/27/2007 | US7196105 Which suppresses I-kappa-B-alpha phosphorylation through inhibition kinase activity and downregulating NF-kappa-B; antiproliferative agents |
| 03/27/2007 | US7196095 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 03/27/2007 | US7196093 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7196065 Enteral formulation |
| 03/27/2007 | US7195914 Composition and method for treatment of hypertriglyceridemia |
| 03/27/2007 | US7195890 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia |
| 03/27/2007 | US7195885 Hepatitis C virus assays |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | US7195774 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion |
| 03/27/2007 | US7195769 Bioavailability |
| 03/27/2007 | US7195763 Treating or preventing infections; polyclonal and monoclonal antibodies |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2180841C 1-aminoindan derivatives and compositions thereof |
| 03/26/2007 | CA2560798A1 Administering pharmaceutical compositions to the mammalian central nervous system |
| 03/22/2007 | WO2007033112A1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 03/22/2007 | WO2007032997A1 Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye |
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007032536A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | WO2007032160A1 Marker gene for examining hypertension |
| 03/22/2007 | WO2006119958A3 Use of flibanserin in the treatment of chronic pain |
| 03/22/2007 | WO2006079021A3 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain |
| 03/22/2007 | WO2006031931A3 Reducing er stress in the treatment of obesity and diabetes |
| 03/22/2007 | WO2005115470A3 PHARMACEUTICAL COMPOSITIONS COMPRISING β-CARBOLINE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER |
| 03/22/2007 | WO2005039550A3 Novel medical uses of compounds showing cb1-antagonistic activity and combination treatment involving said compounds |
| 03/22/2007 | US20070066661 Methods and Compositions for the Treatment of Alopecia and Other Disorders of the Pilosebaceous Apparatus |
| 03/22/2007 | US20070066645 Novel compounds |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | US20070066561 Drug delivery and targeting with vitamin B12 conjugates |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066545 Vaginal compositions for treating pelvic tissue infections and traumas |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070066528 Methods and compositions for treating polycystic ovary syndrome |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070065915 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065485 Therapeutic delivery of carbon monoxide |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065442 Compositions and methods for treating hyperimmune response in the eye |
| 03/22/2007 | DE102005044815A1 Verwendung von Inhibitoren des Na+/H+ Austauschers, Subtyp 5 (NHE5) zur Gedächtnisverbesserung Use of inhibitors of the Na + / H + exchanger, subtype 5 (NHE5) for improving memory |
| 03/22/2007 | DE102005042877A1 Use of PDE1A polypeptides, or nucleic acid, for identifying their specific inhibitors, which are useful for treatment and prevention of cardiac insufficiency |
| 03/22/2007 | CA2622597A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | CA2621368A1 Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764120A1 Coatings for medical devices |
| 03/21/2007 | EP1764111A1 Vaginally administered anti-dysrhythmic agents for treating pelvic pain and infertility |
| 03/21/2007 | EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide |
| 03/21/2007 | EP1763576A2 Ex-vivo application of solid microparticulate therapeutic agents |
| 03/21/2007 | EP1763370A1 Formulations comprising a capsaicinoid, a local anesthetic and/or an antipruritic agent for the treatment of pain |
| 03/21/2007 | EP1763369A1 Combinations comprising antimuscarinic agents and corticosteroids |
| 03/21/2007 | EP1763368A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 03/21/2007 | EP1763352A1 Combination product comprising src kinase inhibitor azd0530 and an antioestrogen or egfr-tk-inhibitor |
| 03/21/2007 | EP1651270B1 Medicaments for inhalation comprising betamimetics and an anticholinergic |
| 03/21/2007 | EP1633377B1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 03/21/2007 | EP1479396B1 Agent for controlling circadian rhythm disorder |
| 03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
| 03/21/2007 | EP1399113B1 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |
| 03/21/2007 | EP1385492B1 Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis |
| 03/21/2007 | EP1361867B1 Fibrate-statin combinations with reduced fed-fasted effects |
| 03/21/2007 | EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 03/21/2007 | EP1331228B1 Method of screening antiplatelet |
| 03/21/2007 | EP1303305B1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 03/21/2007 | EP1289529B1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 03/21/2007 | EP1216024B1 Formulation for menopausal women |
| 03/21/2007 | EP1207872B1 Ibuprofen-containing softgels |
| 03/21/2007 | EP1115381B1 Proteinic drug delivery system using membrane mimetics |
| 03/21/2007 | EP1038025B1 Genetic alterations associated with cancer |
| 03/21/2007 | EP0954283B1 Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation |
| 03/21/2007 | EP0902839B1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
| 03/21/2007 | EP0805853B1 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 03/21/2007 | CN2880078Y Composite capsules for treating gastroenteropathy |
| 03/21/2007 | CN1934255A Combination therapy for the treatment of ocular neovascular disorders |